PHIA.AS

Koninklijke Philips N.V. [PHIA.AS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

PHIA.AS Stock Summary

Earnings are expected to rise 33.07% next year

EPS has increased from the previous quarter and is now positive. (Quarter statements)

PHIA.AS's dividend payments are well covered by cash flows with cash payout ratio of 40.6%.

EPS has been decreasing for the past 3 years (Yearly statements)

Profit margins (-0.11%) are lower than the previous year (-0.09%)

PHIA.AS has less than 1 year of cash runway

Top 10 Correlated Stocks

PHIA.AS

In the News

PHIA.AS Financial details

Company Rating

Strong Buy

Market Cap

17.86B

Income

-2.03B

Revenue

18.37B

Book val./share

13.18

Cash/share

1.05

Dividend

0.85

Dividend %

4.3%

Employees

71.52K

Optionable

Shortable

Yes

Earnings

23 Oct 2023

P/E

-8.96

Forward P/E

5.75

PEG

0.2

P/S

1.05

P/B

1.5

P/C

18.41

P/FCF

Quick Ratio

0.6

Current Ratio

1.2

Debt / Equity

0.68

LT Debt / Equity

0.59

EPS (TTM)

-2.3

EPS next Y

3.36

EPS next Q

EPS this Y

-383.08%

EPS next Y

-245.92%

EPS next 5Y

-245.92%

EPS last 5Y

NAN%

Revenue last 5Y

-0.33%

Revenue Q/Q

7.27%

EPS Q/Q

-110.67%

SMA20

-4.76%

SMA50

SMA100

5.26%

Inst Own

Inst Trans

ROA

-7%

ROE

-15%

ROC

-0.02%

Gross Margin

42%

Oper. Margin

-2%

Profit Margin

-11%

Payout

Shs Outstand

971.16M

Shs Float

753.74M

Target Price

52W Range

12.13-20.94

52W High

-3.33%

52W Low

+61.12%

RSI

Rel Volume

1.28

Avg Volume

2.2M

Volume

2.81M

Perf Week

-3.23%

Perf Month

-2.11%

Perf Quarter

13.02%

Perf Half Y

27.06%

Beta

0.830705

Volatility

0.24%, 0.45%

Prev Close

-0.75%

Price

19.334

Change

-0.49%

PHIA.AS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	18.43	20.25	20.6	18.16	20.22
Net income per share	1.11	1.21	1.25	0.65	-1.84
Operating cash flow per share	1.81	2.11	2.93	1.72	-0.2
Free cash flow per share	0.95	1.06	1.94	0.92	-1.11
Cash per share	2.16	1.48	3.4	2.44	1.34
Book value per share	12.3	13.09	12.52	15.28	15.03
Tangible book value per share	0.03	0.52	0.94	0.2	-0.55
Share holders equity per share	12.3	13.09	12.52	15.28	15.03
Interest debt per share	5.17	5.9	7.53	7.59	9.59
Market cap	29.8B	41.04B	41.51B	30.95B	12.35B
Enterprise value	32.94B	45.06B	45.22B	35.63B	19.38B
P/E ratio	27.34	35.14	34.97	50.57	-7.63
Price to sales ratio	1.64	2.11	2.13	1.8	0.69
POCF ratio	16.74	20.21	14.95	19	-71.37
PFCF ratio	31.81	40.32	22.62	35.74	-12.61
P/B Ratio	2.47	3.26	3.5	2.14	0.93
PTB ratio	2.47	3.26	3.5	2.14	0.93
EV to sales	1.82	2.31	2.31	2.08	1.09
Enterprise value over EBITDA	11.53	14.24	14.07	17.64	13.04
EV to operating cash flow	18.5	22.19	16.28	21.87	-112
EV to free cash flow	35.15	44.27	24.64	41.14	-19.79
Earnings yield	0.04	0.03	0.03	0.02	-0.13
Free cash flow yield	0.03	0.02	0.04	0.03	-0.08
Debt to equity	0.4	0.43	0.58	0.48	0.62
Debt to assets	0.19	0.2	0.25	0.23	0.27
Net debt to EBITDA	1.1	1.27	1.15	2.31	4.73
Current ratio	1.21	1.36	1.45	1.39	1.29
Interest coverage	6.51	7.06	7.56	2.94	-0.45
Income quality	1.36	1.7	2.3	2.66	0.11
Dividend Yield	0.01	0.01	0	0.02	0.03
Payout ratio	0.37	0.39	0	0.79	-0.25
Sales general and administrative to revenue	0.03	0.03	0.03	0.03	0.04
Research and developement to revenue	0.1	0.1	0.1	0.11	0.12
Intangibles to total assets	0.46	0.45	0.4	0.46	0.45
Capex to operating cash flow	-0.47	-0.5	-0.34	-0.47	4.66
Capex to revenue	-0.05	-0.05	-0.05	-0.04	-0.05
Capex to depreciation	-0.77	-0.72	-0.62	-0.58	-0.5
Stock based compensation to revenue	-0.03	0.01	0.01	0.01	0.01
Graham number	17.51	18.91	18.78	14.93	24.91
ROIC	0.09	0.07	0.06	0.03	0
Return on tangible assets	0.08	0.08	0.07	0.04	-0.1
Graham Net	-7.43	-8.33	-8.29	-10.04	-12.41
Working capital	1.63B	2.49B	3.49B	2.9B	2.33B
Tangible asset value	25M	505M	890M	187M	-481M
Net current asset value	-4.33B	-4.92B	-4.59B	-6.14B	-7.15B
Invested capital	0.4	0.43	0.58	0.48	0.62
Average receivables	4.1B	4.45B	4.51B	4.14B	4.15B
Average payables	2.2B	2.2B	2.1B	2B	1.92B
Average inventory	2.51B	2.72B	2.88B	3.22B	3.75B
Days sales outstanding	84.24	88.28	80.46	84.4	88.8
Days payables outstanding	87.85	71.89	71.92	68.41	67.56
Days of inventory on hand	102.01	95.42	101.58	126.08	138.99
Receivables turnover	4.33	4.13	4.54	4.32	4.11
Payables turnover	4.15	5.08	5.08	5.34	5.4
Inventory turnover	3.58	3.83	3.59	2.9	2.63
ROE	0.09	0.09	0.1	0.04	-0.12
Capex per share	-0.86	-1.05	-0.99	-0.81	-0.91

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	4.72	4.87	6.14	4.73	4.86
Net income per share	-0.03	-1.5	-0.13	-0.75	0.08
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	1.43	0	1.34	0	1.05
Book value per share	16.66	0	15.01	0	13.18
Tangible book value per share	-0.87	0	-0.54	0	-1.31
Share holders equity per share	16.66	0	15.01	0	13.18
Interest debt per share	9.13	0	9.39	0	9.02
Market cap	18.17B	14.17B	12.36B	14.84B	18.23B
Enterprise value	24.92B	0	19.39B	0	25.48B
P/E ratio	-189.31	-2.66	-27.35	-5.6	63.29
Price to sales ratio	4.35	3.29	2.28	3.56	4.08
POCF ratio	0	0	0	0	0
PFCF ratio	0	0	0	0	0
P/B Ratio	1.23	0	0.93	0	1.5
PTB ratio	1.23	0	0.93	0	1.5
EV to sales	5.97	0	3.58	0	5.7
Enterprise value over EBITDA	732.85	0	153.91	0	127.42
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	0	-0.09	-0.01	-0.04	0
Free cash flow yield	0	0	0	0	0
Debt to equity	0.54	0	0.62	0	0.68
Debt to assets	0.25	0	0.27	0	0.28
Net debt to EBITDA	198.32	0	55.79	0	36.28
Current ratio	1.19	0	1.29	0	1.2
Interest coverage	0.16	-2.88	1.86	-6.27	2.63
Income quality	0	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.03	0.04	0.04	0.04	0.04
Research and developement to revenue	0.12	0.14	0.09	0.13	0.1
Intangibles to total assets	0.48	0	0.45	0	0.45
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	3.19	0	6.57	0	4.82
ROIC	0	0	-0.12	0	0.01
Return on tangible assets	0	0	-0.01	0	0
Graham Net	-13.06	0	-12.4	0	-12.42
Working capital	1.61B	0	2.33B	0	1.62B
Tangible asset value	-771M	0	-481M	0	-1.2B
Net current asset value	-7.69B	0	-7.15B	0	-7.66B
Invested capital	0.54	0	0.62	0	0.68
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	82.14	0	71.99	0	77.84
Days payables outstanding	66.48	0	55.33	0	59.07
Days of inventory on hand	150.92	0	113.84	0	146.95
Receivables turnover	1.1	0	1.25	0	1.16
Payables turnover	1.35	0	1.63	0	1.52
Inventory turnover	0.6	0	0.79	0	0.61
ROE	0	0	-0.01	0	0.01
Capex per share	0	0	0	0	0

PHIA.AS Dividend History

PHIA.AS Frequently Asked Questions

What is Koninklijke Philips N.V. stock symbol ?

Koninklijke Philips N.V. is a NL stock and trading under the symbol PHIA.AS

What is Koninklijke Philips N.V. stock quote today ?

Koninklijke Philips N.V. stock price is $19.334 today.

Is Koninklijke Philips N.V. stock public?

Yes, Koninklijke Philips N.V. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 2.2M
Market Capitalization 17.86B
Employee 71.52K
CEO Mr. Roy Jakobs
Headquarters Amsterdam,NL
IPO Date 1995-03-27
Website https://www.philips.com

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.